申请人:The University of Kentucky Research Foundation
公开号:EP0023704A2
公开(公告)日:1981-02-11
The invention relates to a novel method of administering propranolol, a known β-andrenergic blocking agent widely used in the treatment of angina pectoris, arrhythmias, hypertension and other cardiac conditions, and migraine. The invention further relates to novel dosage forms of propranolol which are adapted for nasal administration and which include solutions, suspensions, gels and ointments.
本发明涉及一种新型的普萘洛尔给药方法,普萘洛尔是一种已知的β-肾上腺素能阻断剂,广泛用于治疗心绞痛、心律失常、高血压和其他心脏疾病以及偏头痛。 本发明还涉及普萘洛尔的新型剂型,这种剂型适用于鼻腔给药,包括溶液剂、混悬剂、凝胶剂和软膏剂。